zuunharaa
Published 4 weeks ago • 111 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
2:11
molecular actions of the pml-rarα fusion protein in promyelocytic leukaemia hd
-
1:41
elotuzumab plus pomalidomide and dexamethasone for multiple myeloma
-
1:34
zanidatamab and chemotherapy in her2 gastroesophageal cancer
-
0:16
huabang ammonia nitrogen absorption chlorolite to prevent root rot medium succulent plant
-
4:25
biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monother...
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
5:18
inflammation as a biomarker of successful aging — evidence in semi-supercentenarians
-
7:37
zanidatamab for her2-amplified, unresectable, locally advanced or metastatic biliary tract cancer
-
2:53
qiuayua
-
5:55
bone cancer explained: symptoms, causes, stages, and treatment
-
1:27
leader: biomarker analyses of lenvatinib plus eribulin for sarcoma
-
4:55
nabazhen (teiterium remix)
-
2:57
zebra biological facts and truth
-
6:42
gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic aml
-
4:28
i-doublediff & cora technologies - horiba yumizen h550e & yumizen h500e cbc esr analyzers
-
9:01
know about medication label
-
0:14
ignite transformation - new yumizen c coming soon #yumizenc
-
2:37
video synopsis: jingru tian, jun lu and colleagues (the embo journal)
-
0:52
imroz trial updates: isa-vrd versus vrd in patients with ndmm ineligible for transplant
-
1:47
identification of commensal microbiota bound by host immunoglobulins
-
5:22
icaria study: isatuximab and pom/dex for multiple myeloma
-
2:17
choosing between inotuzumab ozogamicin and blinatumomab in patients with r/r all